能量调整的饮食炎症指数与总免疫球蛋白E之间的关联:一个横截面研究
Liang Su1,2, Fang Wang3, Cheng Qin3
1Department of Dermatology The First Affiliated Hospital of Yunnan University of Chinese Medicine Kunming China.
Food science & nutrition
|March 8, 2024
概括
通过饮食炎症指数 (DII) 测量的促炎症饮食,显示没有与成人总免疫球蛋白E (IgE) 的联系. 然而,超重个体具有较高的DII可能会面临增加IgE水平.
科学领域:
- 营养科学 营养科学
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
背景情况:
- 饮食炎症指数 (DII) 评估了饮食的促炎潜力.
- 促炎症饮食与过敏性疾病之间的联系正受到越来越多的关注.
- DII和免疫球蛋白E (IgE) 水平之间的关联仍然不清楚.
研究的目的:
- 为了研究能量调整后的DII (E-DII) 和总IgE之间的关联.
- 探索身体质量指数 (BMI) 在这种关系中的潜在调解作用.
主要方法:
- 分析了2005-2006年国家健康和营养检查调查数据.
- 包括3614名成年参与者.
- 使用线性回归,逻辑回归和按BMI分层的子组分析进行评估.
主要成果:
- 在整个成年人群中,E-DII和总IgE之间没有发现统计学意义上的关联.
- 在超重的参与者中,较高的E-DII与总IgE的升高显著相关.
- 在超重子组中,BMI没有调解E-DII和总IgE之间的关联.
结论:
- 通过E-DII测量的饮食性炎症与一般成年人群的IgE总量无关.
- 超重的个体食用更多的促炎饮食可能有较高的总IgE升高的风险.
- 需要进一步研究,以了解超重人群中饮食炎症和IgE之间的具体机制.
更多相关视频
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
10.0K
09:04DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
47.4K
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Enzyme-Linked Immunosorbent Assay
13.0K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
13.0K
